Baseline characteristics | n = 41 |
---|---|
Age (years) | 61 (27–76) |
Male [n (%)] | 30 |
Weight (kg) | 71 (52–110) |
Height (cm) | 172 (152–192) |
BMI (kg/m2) | 25.1 (17.9–35.9) |
Atherosclerosis risk factors | |
Tobacco use [n (%)] | 9 (22) |
Arterial hypertension [n (%)] | 21 (51) |
Diabetes mellitus [n (%)] | 15 (36) |
Peripheral artery disease [n (%)] | 3 (7) |
Chronic heart failure [n (%)] | 4 (10) |
Long-term anticoagulation before VA-ECMO [n (%)] | 3 (7) |
Antiplatelet therapy before VA-ECMO [n (%)] | 8 (19) |
Admission | |
Cardiac arrest [n (%)] | 24 (58) |
Refractory cardiac arrest (n) | 5 |
No flow duration (min) | 1 (0–1) |
Low flow duration (min) | 55 (30–70) |
Resuscitated cardiac arrest (n) | 19 |
No flow duration (min) | 1 (0–15) |
Low flow duration (min) | 15 (1–55) |
STEMI [n (%)] | 23 (56) |
Associated PCI [n (%)] | 18 (43) |
LVEF (%)a | 15 (5–55) |
SOFA score | 10 (3–15) |
Procedural characteristics | |
Success of implantation [n (%)] (%) | 41 (100) |
Reperfusion cannula [n (%)] | 40/41 (97) |
Cannulation time (min) | 20 (10–40) |